Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus
AbstractCrimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen that causes high morbidity and mortality. Efficacy of vaccines and antivirals to treat human CCHFV infections remains limited and controversial. Research into pathology and underlying molecular mechanisms of CCHFV and other nairoviruses is limited. Significant progress has been made in our understanding of CCHFV replication and pathogenesis in the past decade. Here we review the most recent molecular advances in CCHFV-related research, and provide perspectives on future research. View Full-Text
Share & Cite This Article
Zivcec, M.; Scholte, F.E.M.; Spiropoulou, C.F.; Spengler, J.R.; Bergeron, É. Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus. Viruses 2016, 8, 106.
Zivcec M, Scholte FEM, Spiropoulou CF, Spengler JR, Bergeron É. Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus. Viruses. 2016; 8(4):106.Chicago/Turabian Style
Zivcec, Marko; Scholte, Florine E.M.; Spiropoulou, Christina F.; Spengler, Jessica R.; Bergeron, Éric. 2016. "Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus." Viruses 8, no. 4: 106.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.